Covered recipient · General Payments record
NATHAN HEFLIN MASSEY
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,818.48
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $605.12 | 23 |
| Education | $13.76 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $271.98 | 17 |
| Janssen Scientific Affairs, LLC | $143.59 | 1 |
| Janssen Biotech, Inc. | $120.35 | 1 |
| SHIELD THERAPEUTICS INC | $18.36 | 1 |
| Lilly USA, LLC | $18.33 | 1 |
| PFIZER INC. | $17.83 | 1 |
| Celgene Corporation | $14.68 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.44 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980797 | CMS |
| ABBVIE INC. | $16.44 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980799 | CMS |
| ABBVIE INC. | $7.59 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980801 | CMS |
| ABBVIE INC. | $22.06 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980803 | CMS |
| ABBVIE INC. | $23.42 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980805 | CMS |
| ABBVIE INC. | $4.09 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980807 | CMS |
| ABBVIE INC. | $12.46 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980809 | CMS |
| ABBVIE INC. | $4.76 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980811 | CMS |
| ABBVIE INC. | $27.98 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980813 | CMS |
| ABBVIE INC. | $21.30 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980815 | CMS |
| ABBVIE INC. | $8.98 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980817 | CMS |
| ABBVIE INC. | $21.87 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980819 | CMS |
| ABBVIE INC. | $17.80 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980821 | CMS |
| ABBVIE INC. | $16.20 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980823 | CMS |
| ABBVIE INC. | $19.27 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980825 | CMS |
| ABBVIE INC. | $4.97 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980827 | CMS |
| ABBVIE INC. | $20.35 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104980829 | CMS |
| Celgene Corporation | $14.68 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101128284 | CMS |
| Janssen Biotech, Inc. | $120.35 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078652330 | CMS |
| Janssen Scientific Affairs, LLC | $143.59 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078850848 | CMS |
| Lilly USA, LLC | $18.33 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135238745 | CMS |
| PFIZER INC. | $17.83 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131842846 | CMS |
| SHIELD THERAPEUTICS INC | $18.36 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150116735 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 05/24/2024 | Education | Undisputed | 01/23/2026 | 1137630899 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.